Organization

The University of Texas Health Science Center at Houston

82 clinical trials

9 abstracts

Abstract
Clinical and analytical validation of a targeted gene expression biomarker predicting meningioma outcomes and radiotherapy responses.
Org: University of California-San Francisco, University of Chicago Medical Center, Chicago, IL, University of California San Francisco, University Clinic of Heidelberg, UCSF Department of Radiation Oncology,
Abstract
Viral hepatitis screening in patients with early breast cancer receiving cancer therapy: A quality improvement initiative.
Org: The University of Texas Health Science Center at Houston, The University of Texas MD Anderson Cancer Center,
Abstract
Importance of information-seeking styles among patients with cancer pre- and post-treatment: A URCC NCORP Research Base study.
Org: University of Rocheser Medical Center, Rochester, NY, James P. Wilmot Cancer Center, University of Rochester Medical Center, University of Rochester,
Clinical trial
Intercostal Nerve Cryoablation for Postoperative Pain Management
Status: Completed, Estimated PCD: 2022-09-22
Clinical trial
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
Status: Recruiting, Estimated PCD: 2024-10-01
Abstract
Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancer.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston,
Abstract
Pathways for provider initiated genetic testing to bridge the gap in germline genetic testing for metastatic breast cancer.
Org: The University of Texas Health Science Center at Houston, McGovern Medical School, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,
Abstract
The impact of HIV and CD4 count stratification on all cause mortality for adenocarcinoma and squamous cell lung cancers in the antiretroviral therapy era: Analysis of National Veterans Affairs and Kaiser Permanente Northern cohorts.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston, MD Anderson Cancer Center, Baylor College of Medicine, Baylor College of Medicine Division of Diabetes Endocrinology and Metabolism,
Abstract
The timing of checkpoint inhibition in relation to stem cell transplantation increases the risk of inflammatory adverse events.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston, Baylor College of Medicine, The University of Texas Health Sciences Center, Texas A&M Unniversity,
Abstract
Plasma growth hormone as a prognostic biomarker to durvalumab and tremelimumab in patients with advanced hepatocellular carcinoma.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, Massachusetts General Hospital, The University of Texas Health Science Center at Houston, McGovern Medical School,
Clinical trial
Ketorolac in Palatoplasty: A Randomized Blinded Controlled Trial.
Status: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Status: Active (not recruiting), Estimated PCD: 2023-10-06
Clinical trial
Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy
Status: Completed, Estimated PCD: 2022-08-31
Clinical trial
Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
Status: Withdrawn, Estimated PCD: 2022-06-30
Clinical trial
Houston Emergency Engagement System for Youths and Adolescents
Status: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
UTHealth Turner Syndrome Research Registry
Status: Recruiting, Estimated PCD: 2030-01-01
Clinical trial
Houston Emergency Opioid Engagement System (HEROES)
Status: , Estimated PCD: 2024-08-31
Clinical trial
Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development
Status: Completed, Estimated PCD: 2022-10-01
Clinical trial
The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors
Status: Active (not recruiting), Estimated PCD: 2024-05-31
Clinical trial
General Evaluation of Eligibility for Substance Abuse/Dependence Research
Status: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Suvorexant to Reduce Symptoms of Nicotine Use: A Double-blind, Placebo-controlled Study
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Pre-surgical Ultrasound Evaluation for Improving Patient Selection for vNOTES Approach
Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Ketamine for Acute Pain After Trauma: KAPT Trial
Status: Completed, Estimated PCD: 2022-03-30
Clinical trial
Evaluation of Aerosol in a Dental Clinic
Status: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
Platelet Transfusion During Neonatal Open Heart Surgery
Status: Completed, Estimated PCD: 2018-10-01
Clinical trial
Postmenopausal Pessary Users: Estrogen Versus Trimosan
Status: Terminated, Estimated PCD: 2021-03-08
Clinical trial
Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis
Status: Terminated, Estimated PCD: 2022-02-07
Clinical trial
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder: A Pilot Study
Status: Not yet recruiting, Estimated PCD: 2025-06-30
Abstract
Prognostic stratification and outcome of metastatic NSCLC based on activating mutation profile and PD-L1 status.
Org: The University of Texas Health Science Center at Houston, UTHealth Houston, McGovern Medical School,